Full Measure with Sharyl Attkisson - Hydroxychloroquine and Remdesivir
May 17, 2020
Sharyl Attkisson's latest Full Measure episode reports on politics, money, and medicine colliding with the COVID-19 crisis.
Attkisson interviews three accomplished medical experts who are calling for the politicization of COVID-19 to come to a screeching halt because it is dangerous, scaring patients, and costing lives and the financial conflicts of interests must be further examined.
They also note that the media is not helping the situation.
Dr. Stephen Hatfield, a biomedical scientist who worked on Ebola asks, "Why are the press running medicine in the United States? This is not right."
"I've never seen science politicized in 40 years of practice," says, Dr. William O'Neill, a cardiologist and Medical Director at the Henry Ford Health System in Detroit, Michigan, where clinical trials are being conducting with both hydroxychloroquine and remdesivir on COVID-19 patients.
Dr. O'Neill says some in the field believe there is some value with hydroxychloroquine and agrees the drug has to be tested, but wants everyone to "hold their powders," and eventually there will be more clarity on what treatment works.
To those patients prescribed hydroxychloroquine, Dr. O'Neill claims, "I have seen no single side effect of harm." Dr. O'Neill tells Full Measure that he has found value and improvement in all of the patients.
He is studying hydroxychloroquine as a COVID-19 preventative drug and has tested it on 400 patients.
Dr. Jane Orient, Executive Director of the Association of American Physicians and Surgeons (AAPS), told Full Measure that those who support remdesivir may have some "conflicts of interests," and that the financial ties must be examined.
"I think you have to look at the money, says Dr. Orient, "There is no big money in hydroxychloroquine."
https://justthenews.com/politics-policy/full-measure-sharyl-atkkisson-hydroxychloroquine-and-remdesivir
Hydroxychloroquine
SUNDAY, MAY 17TH 2020
http://fullmeasure.news/news/cover-story/hydroxychloroquine